Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Viking Thera (VKTX)

Viking Thera (VKTX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
23.91 -0.24 (-0.99%) 04/01/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 23.88 -0.03 (-0.13%) 19:26 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
23.29
Day High
24.54
Open 24.15
Previous Close 24.15 24.15
Volume 3,671,800 3,671,800
Avg Vol 3,759,500 3,759,500
Stochastic %K 11.90% 11.90%
Weighted Alpha -72.35 -72.35
5-Day Change -4.07 (-14.55%) -4.07 (-14.55%)
52-Week Range 23.27 - 81.86 23.27 - 81.86
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,710,789
  • Shares Outstanding, K 112,248
  • Annual Sales, $ 0 K
  • Annual Income, $ -109,960 K
  • EBIT $ -151 M
  • EBITDA $ -168 M
  • 60-Month Beta 0.90
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.25

Options Overview Details

View History
  • Implied Volatility 81.07% ( -8.41%)
  • Historical Volatility 89.73%
  • IV Percentile 23%
  • IV Rank 23.52%
  • IV High 128.97% on 07/10/24
  • IV Low 66.34% on 02/11/25
  • Put/Call Vol Ratio 0.12
  • Today's Volume 15,411
  • Volume Avg (30-Day) 17,677
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 199,685
  • Open Int (30-Day) 183,889

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.34
  • Number of Estimates 10
  • High Estimate -0.26
  • Low Estimate -0.40
  • Prior Year -0.26
  • Growth Rate Est. (year over year) -30.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.27 +2.75%
on 03/31/25
Period Open: 28.87
31.48 -24.05%
on 03/14/25
-4.96 (-17.18%)
since 02/28/25
3-Month
23.27 +2.75%
on 03/31/25
Period Open: 40.24
43.55 -45.10%
on 01/06/25
-16.33 (-40.58%)
since 12/31/24
52-Week
23.27 +2.75%
on 03/31/25
Period Open: 79.50
81.86 -70.79%
on 05/07/24
-55.59 (-69.92%)
since 04/01/24

Most Recent Stories

More News
Which Healthcare Stock Is the Best Buy Right Now?

Healthcare stocks provide a combination of upstarts with a high risk, high reward proposition to established firms that can be a defensive maneuver.

VKTX : 23.91 (-0.99%)
NVO : 68.03 (-2.03%)
LLY : 805.23 (-2.50%)
ABSI : 2.40 (-4.38%)
ELV : 432.68 (-0.52%)
Motley Fool 2025 March Market Cap Showdown Championship

It all comes down to this...the final round of the Motley Fool Rule Breaker Investing March Market Cap Showdown! Defending Champion Andy Cross has held off all contenders and pretenders, but game show...

TWLO : 98.17 (+0.27%)
AMAT : 145.66 (+0.37%)
APP : 282.70 (+6.69%)
AAPL : 223.19 (+0.48%)
NDAQ : 76.04 (+0.24%)
HLF : 8.81 (+2.09%)
BRZE : 36.37 (+0.80%)
KMI : 28.63 (+0.35%)
NVO : 68.03 (-2.03%)
PTON : 6.22 (-1.58%)
WIX : 164.00 (+0.38%)
BRK.TO : 39.95 (+0.13%)
Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

It's hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug market is expected to generate $12.8 billion in sales this year, and according...

VKTX : 23.91 (-0.99%)
NVO : 68.03 (-2.03%)
LLY : 805.23 (-2.50%)
MarketBeat Week in Review – 03/17 - 03/21

Stocks gained after the Fed meeting but drifted lower after disappointing guidance from FedEx; next week's inflation data is unlikely to provide needed clarity

APP : 282.70 (+6.69%)
NVDA : 110.15 (+1.63%)
SMCI : 35.05 (+2.37%)
ORCL : 141.94 (+1.52%)
RKLB : 18.15 (+1.51%)
BROS : 61.35 (-0.63%)
LUV : 31.59 (-5.93%)
LUNR : 7.47 (+0.27%)
DIS : 97.68 (-1.03%)
TSM : 168.64 (+1.59%)
VKTX : 23.91 (-0.99%)
OXY : 49.19 (-0.34%)
1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street

Last year, Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech, attracted the market's attention thanks to excellent midstage clinical trial results. The company's shares soared in late February 2024,...

VKTX : 23.91 (-0.99%)
Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?

Viking Therapeutics (NASDAQ: VKTX) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may eventually rake in significant revenue from the anti-obesity market. It has demonstrated...

VKTX : 23.91 (-0.99%)
Is Novo Nordisk a No-Brainer Buy After It Dropped 40%?

In this video, I will cover the recent updates regarding Novo Nordisk (NYSE: NVO) . Watch the short video to learn more, consider subscribing, and click the special offer link below.

VKTX : 23.91 (-0.99%)
NVO : 68.03 (-2.03%)
Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?

Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug.

VKTX : 23.91 (-0.99%)
NVO : 68.03 (-2.03%)
HIMS : 31.05 (+5.08%)
LLY : 805.23 (-2.50%)
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

Ignore the noise in GLP-1 stocks. Find the best value instead.

VKTX : 23.91 (-0.99%)
NVO : 68.03 (-2.03%)
LLY : 805.23 (-2.50%)
RHHBY : 41.0800 (-0.17%)
CordenPharma and Viking Therapeutics Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables and Oral Formulations

/CNW/ -- CordenPharma, a leading Contract Development & Manufacturing Organization (CDMO) specializing in the supply of peptide APIs and peptide-based...

VKTX : 23.91 (-0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 25.79
2nd Resistance Point 25.16
1st Resistance Point 24.54
Last Price 23.91
1st Support Level 23.29
2nd Support Level 22.66
3rd Support Level 22.04

See More

52-Week High 81.86
Fibonacci 61.8% 59.48
Fibonacci 50% 52.57
Fibonacci 38.2% 45.65
Last Price 23.91
52-Week Low 23.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies